Blog - Page 3148 of 5752

MondayFeb 11, 2013 7:39 am

Document Security Systems, Inc. (DSS) Prepares Authentiguard® Authentication Solution Beta Test for iPhones

Document Security Systems, a prominent developer of anti-counterfeiting, anti-fraud, and authentication technologies for governments, corporations, and financial institutions, announced that its patented iPhone application for authentication, AuthentiGuard®, will enter the Beta testing phase. The target market for the application is major pharmaceutical and other companies worldwide. Later this year, testing on other platforms, such as Android, is expected to take place. DSS’ innovative, cloud enabled app will greatly reduce the use of expensive proprietary authentication hardware and the need for complex training. It allows for the efficient and cost effective authentication for packaging, documents, and credentials. Customizable AuthentiGuard® Prism Technology…

MondayFeb 11, 2013 7:38 am

Trunity Holdings, Inc. (TNTY) Education Solution Utilized by Scientists to Produce, Deliver Environmental Science Course at Boston University

Trunity Holdings, a provider of eLearning content and solutions, announced that environmental scientists Drs. Robert K. Kaufmann and Cutler J. Cleveland have authored their textbook, Environmental Science, and delivered their course Introduction to Environmental Science at Boston University using Trunity’s education solution. Trunity’s virtual platform allows educators a variety of authoring capabilities, including the ability to establish a curriculum; create and deliver course-related content, including embedding video, high resolution image galleries, and graphics; and monitor students’ progress. Students can access the course material via iPad, tablet, PC, smartphone, or any browser-based connected device. The virtual textbook enhances learning opportunities with…

FridayFeb 08, 2013 7:02 pm

eCrypt Technologies, Inc. (ECRY) Issues Correction to Press Release

eCrypt Technologies, Inc. announced today a correction to its press release issued on Monday, September 13, 2010 entitled "eCrypt Technologies, Inc (ECRY.OB) Increases Potential Market by Over 4,800%". In the press release, the Company reported that it expanded its potential market by over 4,800% through the development of an email privacy solution compatible with all internet enabled devices, including smartphones, laptops and desktop computers. Through a subsequent review the Company identified a calculation error resulting in an overstatement of the increase. The increase in potential market share should have been reported as "over 3,800%" (3,840%), not "over 4,800%" (4,835%). While…

FridayFeb 08, 2013 10:49 am

POZEN, Inc. (POZN) Presents Positive Phase 3 Data for PA32540 at AHA International Stroke Conference

Today, POZEN presented data from the combined results of two Phase 3 studies of PA32540 in patients with prior cerebrovascular disease. PA32540 is an antiplatelet therapy of enteric-coated (EC) and immediate-release omeprazole. Data from the two studies was presented as poster board No. MP103 on Feb. 7 at the American Heart Association 2013 International Stroke Conference in Honolulu, Hawaii. The studies found that in the post-hoc analysis of subjects with a history of transient ischemic attack (TIA) or stroke, receiving long-term treatment (six months) of PA32540, as compared with EC-ASA (325 mg), was associated with a substantially reduced rate of…

FridayFeb 08, 2013 7:18 am

Latronix Inc. (LTRX) Receives MacObserver’s Editor’s Choice Award

Leading M2M connectivity service provider Lantronix announced that its xPrintServer™—Office Edition won MacObserver’s Editor’s Choice Award during Macworld | iWorld 2013. The xPrintServer—Office Edition is designed for business and IT professionals who wish to print from their iPad®, iPhone®, or iPod® to any printer. As the industry’s first and only plug-and-print hardware solution for printing from virtually any iOS device, the xPrintServer—Office Edition offers automatic printer discovery and no configuration, making printing hassle-free. Users only have to open the box, plug in power and Ethernet, and print from an iOS device to any USB or network-connected printer, whether wired or…

ThursdayFeb 07, 2013 3:34 pm

Cereplast (CERP) Names Michael Okada as Chief Financial Officer

Cereplast, a manufacturer of proprietary biobased, sustainable bioplastics, has appointed Michael Okada to lead the company’s financial initiatives as CFO, effective February 5, 2013. Okada joined Cereplast in April 2011 as vice president and corporate controller and was appointed to the role of chief accounting officer and interim CFO in February 2012. Because of his service as interim CFO for the last year, Cereplast’s board of directors believes Okada will maintain the “considerable accounting and business strength” moving forward. “We are excited to promote Michael as our CFO as he has made exceptional contributions to the Company during the past…

ThursdayFeb 07, 2013 3:34 pm

TransAct Energy Corp. (TEGY) Initial Phases of Joint Development Agreement Complete

TransAct Energy, the San Antonio-headquartered sustainable energy developer with its hands in many different aspects of the space from waste/energy conversion to wind, solar, and even geothermal, took some time out today to update markets on the previously announced (July 18, 2012) joint development agreement (JDA) with Mr. Bruce Hutchon, Utopial Limited, and Halfuel Limited. The JDA-formed joint entity has Hutchon transferring his proprietary, emissions-free, and exceptionally clean waste-to-energy technology, as well as the operating 20 tonne pilot plant and all the associated research done thus far, over to the new joint corporation structure. TransAct will kick in some $100M…

ThursdayFeb 07, 2013 11:46 am

Aristocrat Group Corp. (ASCC) Nearing Finalization on Distillation Contract, Plans to Promote New Vodka in Upcoming Feature Film Series

Aristocrat Group’s distilled spirits are set to appear in the upcoming feature film “Killing Time,” and the company is working swiftly to get its inaugural liquor product on store shelves before the film’s premiere. Currently, ASCC is finalizing a deal with an auspicious U.S. distillery to produce its new vodka, which is being promoted by ASCC’s brand management division, Luxuria Brands. The distiller is based in Idaho and produces spirits using pure well water, which is one of ASCC’s strict requirements for creating an ultra-premium vodka with superior taste. “We’ve been highly impressed by this particular distiller’s craftsmanship and success,”…

ThursdayFeb 07, 2013 11:45 am

VistaGen Therapeutics, Inc. (VSTA) Progress in the Labs Enable Advanced Tools for Drug Rescue and Potential Cell Therapies

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, earlier today announced significant advancements in its stem cell technology licensed from the University Health Network (UHN) in Toronto, Canada. The advancements improve the company’s ability to develop new stem cell-based bioassay systems and potentially improved cell therapies for human blood system disorders. “In collaboration with our long-term strategic partners at UHN, we continue to pioneer stem cell technology that promises to change the way we develop medicine and apply treatment,” stated Shawn K. Singh, CEO of VistaGen. “In addition to creating…

ThursdayFeb 07, 2013 11:44 am

CollabRx, Inc. (CLRX) Releases New Version of Lung Cancer Support Tool for Oncologists

CollabRx is a leading company in cloud-based expert systems to inform healthcare decision-making. The company uses integration technology to aggregate and contextualize the world’s knowledge on genomics-based medicine with specific insights from the nation’s top cancer experts. The company announced today the release of its second generation Therapy Finder application for lung cancer. This specific application is a web-based decision support tool that enables oncologists to take into account the genetics of a patient’s tumor when determining a treatment plan. This second generation incorporates the results of recent advances in lung cancer clinical and translational research. The app content is…

Site Search

Company Search